The Enterprise Value as of September 2024 (TTM) for BioMarin Pharmaceutical Inc. (BMRN) is 16.13B

According to BioMarin Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.13B. This represents a change of -5.08% compared to the average of 17.00B of the last 4 quarters.

BioMarin Pharmaceutical Inc. (BMRN) Historical Enterprise Value (quarterly & annually)

How has BMRN Enterprise Value performed in the past?

The mean historical Enterprise Value of BioMarin Pharmaceutical Inc. over the last ten years is 16.20B. The current 16.13B Enterprise Value has changed 9.86% with respect to the historical average. Over the past ten years (40 quarters), BMRN's Enterprise Value was at its highest in in the June 2020 quarter at 22.92B. The Enterprise Value was at its lowest in in the September 2014 quarter at 10.87B.

BioMarin Pharmaceutical Inc. (BMRN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioMarin Pharmaceutical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioMarin Pharmaceutical Inc. (BMRN) Average Enterprise Value

How has BMRN Enterprise Value performed in the past?

The current Enterprise Value of BioMarin Pharmaceutical Inc. (BMRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioMarin Pharmaceutical Inc. (BMRN) Enterprise Value vs. Peers

How is BMRN’s Enterprise Value compared to its peers?

BioMarin Pharmaceutical Inc.’s Enterprise Value is less than Seagen Inc. (42.84B), less than Alnylam Pharmaceuticals, Inc. (33.42B), greater than Exelixis, Inc. (7.21B), greater than Halozyme Therapeutics, Inc. (8.85B), greater than Arrowhead Pharmaceuticals, Inc. (3.15B), greater than Incyte Corporation (10.85B), greater than Ionis Pharmaceuticals, Inc. (8.54B), greater than Apellis Pharmaceuticals, Inc. (5.11B), greater than Vaxcyte, Inc. (11.96B), greater than Liquidia Corporation (568.30M), greater than Legend Biotech Corporation (10.04B), greater than Bio-Techne Corporation (11.61B), greater than Mereo BioPharma Group plc (582.99M), greater than Blueprint Medicines Corporation (6.16B), greater than Agios Pharmaceuticals, Inc. (2.44B), greater than Day One Biopharmaceuticals, Inc. (1.01B), greater than IVERIC bio, Inc. (5.14B), greater than Amylyx Pharmaceuticals, Inc. (89.50M), greater than Karuna Therapeutics, Inc. (12.43B),

Build a custom stock screener for BioMarin Pharmaceutical Inc. (BMRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMarin Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioMarin Pharmaceutical Inc. (BMRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioMarin Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.